Skip to main content
. 2023 Dec 19;16(1):7. doi: 10.3390/pharmaceutics16010007

Table 6.

Recent clinical trials on nano-DDSs in OC therapy [197].

ClinicalTrials.Gov Identifier Type of Cancer Nanocarrier Active
Ingredients
Phase Recruitment
Status
NCT05456022 Tongue Squamous Cell Carcinoma Cell Line PLGA-PEG NPs QRC Phase Ⅱ Not yet recruiting
NCT01847326 Squamous Cell Carcinoma of the Hypopharynx; Squamous Cell Carcinoma of the Lip and Oral Cavity HSA NPs PTX Phase I Active, not recruiting